Managing HIV/hepatitis C co-infection in the era of direct acting antivirals

Morbidity and mortality from co-morbid hepatitis C (HCV) infection in HIV co-infected patients are increasing; hence, the management of hepatitis co-infection in HIV is now one of the most important clinical challenges. Therefore, the development of direct acting antivirals (DAAs) for treatment of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockstroh, Jürgen K, Bhagani, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225604/
https://www.ncbi.nlm.nih.gov/pubmed/24228933
http://dx.doi.org/10.1186/1741-7015-11-234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225604/
https://www.ncbi.nlm.nih.gov/pubmed/24228933
http://dx.doi.org/10.1186/1741-7015-11-234

Ejemplares similares